Centene

Summary

In 1984 was created Centene, which is appeared as Corporate Investor. The company was established in North America in United States. The main office of represented Corporate Investor is situated in the St Louis.

The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Centene, startups are often financed by Skyline Ventures, SV Health Investors, Polaris Partners. The meaningful sponsors for the fund in investment in the same round are WuXi Healthcare Ventures, Waterline Ventures, Vida Ventures. In the next rounds fund is usually obtained by National Institutes of Health, National Institute on Aging.

The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the various public portfolio startups of the fund, we may underline Quartet, RxAdvance, RubiconMD Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Pharmaceutical, mHealth.

This Centene works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2018. The increased amount of exits for fund were in 2019. The real fund results show that this Corporate Investor is 30 percentage points more often commits exit comparing to other companies. The fund is constantly included in 2-6 deals per year. Deals in the range of 50 - 100 millions dollars are the general things for fund.